ES Yang, Y Do, SY Cheon, B Kim… - Oncology …, 2023 - spandidos-publications.com
Metabolic disorder is a major characteristic of cancer cells, and controlling genes involved in metabolic shifts can be an effective strategy for cancer treatment. Andrographolide (AG), a …
HH Sheikhhossein, F Iommelli, N Di Pietro, MC Curia… - Vaccines, 2024 - mdpi.com
Cancer remains one of the main causes of death in the world due to its increasing incidence and treatment difficulties. Although significant progress has been made in this field …
C De Rosa, V De Rosa, C Tuccillo, V Tirino, L Amato… - Scientific Reports, 2024 - nature.com
Osimertinib is a third-generation tyrosine kinase inhibitor clinically approved for first-line treatment of EGFR-mutant non-small cell lung cancer (NSCLC) patients. Although an …
X Sun, T Wu, Z Yang, S Chen, Z Zhao, C Hu, S Wu… - Gene, 2024 - Elsevier
Aims To investigate the association between mitochondrial events and immune response in periodontitis and related regulatory genes. Main methods Gene expression profiles in …
Background and rationale: Activation of oncogenes or loss of function of suppressor genes, in addition to induce neoplastic transformation, leads to a reprogramming of glucose …